Renaissance Technologies

Renaissance Technologies Portfolio holdings

AUM $75.8B
1-Year Est. Return 50.56%
 

Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.

This Quarter Est. Return
1 Year Est. Return
+50.56%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$75.8B
AUM Growth
+$582M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
4,038
New
Increased
Reduced
Closed

Top Buys

1 +$633M
2 +$487M
3 +$419M
4
META icon
Meta Platforms (Facebook)
META
+$345M
5
KO icon
Coca-Cola
KO
+$257M

Top Sells

1 +$1.36B
2 +$900M
3 +$583M
4
NVDA icon
NVIDIA
NVDA
+$335M
5
NFLX icon
Netflix
NFLX
+$320M

Sector Composition

1 Technology 21.71%
2 Healthcare 15.16%
3 Consumer Discretionary 11.8%
4 Communication Services 10.53%
5 Financials 9.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VRCA icon
3226
Verrica Pharmaceuticals
VRCA
$130M
$126K ﹤0.01%
29,191
+20,471
LEDS icon
3227
SemiLEDS
LEDS
$14.2M
$126K ﹤0.01%
57,413
+23,313
AAME icon
3228
Atlantic American Corp
AAME
$50M
$124K ﹤0.01%
43,100
+9,700
DARE icon
3229
Dare Bioscience
DARE
$32.6M
$124K ﹤0.01%
58,895
-12,900
ARMP icon
3230
Armata Pharmaceuticals
ARMP
$197M
$123K ﹤0.01%
41,296
+2,400
VVOS icon
3231
Vivos Therapeutics
VVOS
$17.8M
$122K ﹤0.01%
+39,279
SST icon
3232
System1
SST
$36.3M
$121K ﹤0.01%
17,120
+5,100
MVIS icon
3233
Microvision
MVIS
$278M
$119K ﹤0.01%
+96,261
GTN.A icon
3234
Gray Media Inc
GTN.A
$850M
$118K ﹤0.01%
12,200
AFRI icon
3235
Forafric Global
AFRI
$303M
$116K ﹤0.01%
13,400
-200
UA icon
3236
Under Armour Class C
UA
$1.85B
$115K ﹤0.01%
23,800
-783,500
CTOR
3237
Citius Oncology
CTOR
$96.7M
$113K ﹤0.01%
+55,900
GURE
3238
DELISTED
Gulf Resources
GURE
$113K ﹤0.01%
20,203
+5,859
SINT icon
3239
SiNtx Technologies
SINT
$13.6M
$113K ﹤0.01%
+27,552
PPSI icon
3240
Pioneer Power Solutions
PPSI
$40.2M
$107K ﹤0.01%
24,752
-8,392
OXBR icon
3241
Oxbridge Re Holdings
OXBR
$10.1M
$106K ﹤0.01%
59,000
+25,778
ALLR
3242
Allarity Therapeutics
ALLR
$16.1M
$105K ﹤0.01%
+66,186
INCR
3243
Intercure
INCR
$79.3M
$104K ﹤0.01%
63,700
+14,800
RFL icon
3244
Rafael Holdings
RFL
$64.2M
$104K ﹤0.01%
76,431
+46,600
COSM icon
3245
Cosmos Holdings
COSM
$17.7M
$103K ﹤0.01%
+92,800
LPCN icon
3246
Lipocine
LPCN
$23.3M
$103K ﹤0.01%
36,097
+1,300
WRAP icon
3247
Wrap Technologies
WRAP
$112M
$101K ﹤0.01%
46,700
-100
CLSD
3248
DELISTED
Clearside Biomedical
CLSD
$100K ﹤0.01%
25,247
-7,859
GROV icon
3249
Grove Collaborative
GROV
$50.1M
$100K ﹤0.01%
66,700
+5,100
ARKO icon
3250
ARKO Corp
ARKO
$562M
$99.6K ﹤0.01%
+21,800